https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-01-01 / J Immunother 2012 Jan;35(1):54-65
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-01-01 / J Immunother 2012 Jan;35(1):54-652012-01-01 00:00:002023-03-07 13:05:51A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-10-20 / J Transl Med 2011 Oct;9:178
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-10-20 / J Transl Med 2011 Oct;9:1782011-10-20 00:00:002019-02-15 08:50:33Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-08-16 / J. Mol. Med. 2011 Dec;89(12):1231-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-08-16 / J. Mol. Med. 2011 Dec;89(12):1231-402011-08-16 00:00:002019-02-15 08:50:07HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-06-01 / Front Biosci (Schol Ed) 2011 Jun;3:1486-99
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-06-01 / Front Biosci (Schol Ed) 2011 Jun;3:1486-992011-06-01 00:00:002019-02-15 08:50:08Cancer stem cells: perspectives of new therapeutical approaches for breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-03-29 / Oncol. Rep. 2011 Jun;25(6):1573-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-03-29 / Oncol. Rep. 2011 Jun;25(6):1573-92011-03-29 00:00:002011-03-29 00:00:00Effect of hyperthermia on invasion ability and TGF-β1 expression of breast carcinoma MCF-7 cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-11 / Radiother Oncol 2010 Dec;97(3):535-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-11 / Radiother Oncol 2010 Dec;97(3):535-402010-11-11 00:00:002010-11-11 00:00:00Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-11 / Cancer Immunol. Immunother. 2011 Jan;60(1):87-97
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-11 / Cancer Immunol. Immunother. 2011 Jan;60(1):87-972010-11-11 00:00:002019-02-15 08:50:09An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-06-08 / Cancer Immunol. Immunother. 2010 Sep;59(9):1295-312
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-06-08 / Cancer Immunol. Immunother. 2010 Sep;59(9):1295-3122010-06-08 00:00:002019-02-15 08:50:10Anti-HER2 vaccines: new prospects for breast cancer therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-02-24 / Cell. Immunol. 2010;263(1):9-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-02-24 / Cell. Immunol. 2010;263(1):9-212010-02-24 00:00:002019-02-15 08:50:11Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2/neu induced protective antitumor immunity in two lines of Her-2/neu transgenic mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Int J Hyperthermia 2010;26(7):612-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Int J Hyperthermia 2010;26(7):612-72010-01-01 00:00:002010-01-01 00:00:00Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data
